Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperandrogenism × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 665 Precursor Cell Lymphoblastic Leukemia-Lymphoma 143 Recurrence 106 Neoplasms, Plasma Cell 97 Leukemia 78 Lymphoma 74 Neoplasms 70 Vomiting 47 Burkitt Lymphoma 44 Lymphoma, Non-Hodgkin 41 Immunoglobulin Light-chain Amyloidosis 40 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Mantle-Cell 31 Nausea 30 Prostatic Neoplasms 29 Lymphoma, Follicular 27 Waldenstrom Macroglobulinemia 26 Neoplasm Metastasis 23 Breast Neoplasms 23 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Myeloid, Acute 22 Hodgkin Disease 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 19 Amyloidosis 16 Lymphoma, Extranodal NK-T-Cell 14 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Biphenotypic, Acute 14 Colorectal Neoplasms 13

Interventions

Metformin 7 Progesterone 5 Spironolactone 4 drospirenone and ethinyl estradiol combination 3 Inositol 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 Folic Acid 2 Flutamide 2 Cyproterone Acetate 2 Clomiphene 2 maltodextrin 1 licogliflozin 1 bicalutamide 1 Yoga 1 Topiramate 1 Thioctic Acid 1 Sugars 1 Sodium Salicylate 1 Phlebotomy 1 Ovidrel 1 Magnesium 1 Lactalbumin 1 Inulin 1 Estradiol 1 Dexamethasone 1 Cyproterone acetate, ethinyl estradiol drug combination 1 Carnitine 1 Bloodletting 1 Blood Donation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡